Phaos Technology Holdings (Cayman) (POAS) Retained Earnings (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Retained Earnings of -$10.5 million for Q4 2025, down 15.44% on a QoQ basis from -$9.1 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Retained Earnings data on file, last reported at -$10.5 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings changed N/A year-over-year to -$10.5 million; the trailing twelve-month figure through Oct 2025 stood at -$10.5 million (changed N/A YoY), and the FY2025 full-year result was -$9.3 million, down 78.55% from the prior year.
- Retained Earnings for Q4 2025 stood at -$10.5 million, down from -$9.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$5.2 million in Q2 2024 and bottomed at -$10.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - | -10.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -10.51 Mn |
| Apr 30, 2025 | -9.10 Mn |
| Apr 30, 2024 | -5.22 Mn |